Boguslaw Sieczkowski
Chief Executive Officer chez SELVITA S.A.
Fortune : 27 M $ au 31/03/2024
Profil
Mr. Boguslaw Sieczkowski is a Chief Executive Officer at Selvita SA. Mr. Sieczkowski was previously employed as a COO, EVP & Member-Management Board by Ryvu Therapeutics SA and a Vice President by Comarch SA. He also served on the board at CDN SA. He received his graduate degree from Uniwersytet Jagiellonski, an MBA from Cracow University of Economics and an MBA from the University of Teesside.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
SELVITA SA
5,13% | 08/11/2022 | 942 417 ( 5,13% ) | 16 M $ | 31/03/2024 |
RYVU THERAPEUTICS SA
3,57% | 31/12/2022 | 825 348 ( 3,57% ) | 11 M $ | 31/03/2024 |
Postes actifs de Boguslaw Sieczkowski
Sociétés | Poste | Début |
---|---|---|
SELVITA S.A. | Chief Executive Officer | 30/09/2019 |
Anciens postes connus de Boguslaw Sieczkowski
Sociétés | Poste | Fin |
---|---|---|
COMARCH S.A. | Corporate Officer/Principal | 01/01/2007 |
CDN SA | Director/Board Member | - |
RYVU THERAPEUTICS S.A. | Founder | - |
Formation de Boguslaw Sieczkowski
University of Teesside | Masters Business Admin |
Uniwersytet Jagiellonski | Graduate Degree |
Cracow University of Economics | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
COMARCH S.A. | Technology Services |
RYVU THERAPEUTICS S.A. | Health Technology |
SELVITA S.A. | Health Technology |
Entreprise privées | 1 |
---|---|
CDN SA |